Molecular Endocrinology, Vol 9, 679-690, Copyright © 1995 by Endocrine Society

ARTICLES

Contributions of distal and proximal promoter elements to glucocorticoid regulation of osteocalcin gene transcription

F Aslam, V Shalhoub, AJ van Wijnen, C Banerjee, R Bortell, AR Shakoori, G Litwack, JL Stein, GS Stein and JB Lian
Department of Cell Biology, University of Massachusetts Medical Center, Worcester 01655, USA.

Previous studies identified several glucocorticoid response elements (GREs) in the 5'-promoter region of the rat osteocalcin (OC) gene by purified receptor binding. The present study addresses functionality of the GRE sequences in the proximal promoter at nucleotide (nt) -16 to -1 downstream of the TATA element together with the GRE half-element in the OC box at nt -86 to -81. This was done by assaying glucocorticoid responsiveness [at 10(-6) M dexamethasone (DEX)], and in combination with 10(-8) M 1,25-dihydroxyvitamin D3, of a series of deleted and mutated OC promoter reporter constructs (OCCAT) in osteoblast-like cells, the ROS 17/2.8 rat osteosarcoma line. Promoter deletion analysis revealed an additional GRE in the distal promoter at nt -697 to -683 that functions to suppress OC transcription. In the absence of this upstream negative GRE (nGRE), the -531 OCCAT construct exhibited enhanced promoter activity in response to DEX (1.8-fold DEX/Control), but further deletion (-348 and -108 OCCAT constructs) restored DEX suppression to OC promoter activity (0.6- and 0.8-fold DEX/Control, respectively). Mutations introduced in both the proximal GRE (nt -16 to -1) and the half-GRE in the OC box, or in the proximal GRE alone, nearly abrogated DEX responsiveness of OC promoter activity. Both distal and proximal GREs specifically bound glucocorticoid receptor present in ROS 17/2.8 nuclear extracts as shown by competition with wild type and mutated oligonucleotides and antibody inhibition of binding. Furthermore, both GREs, independently, conferred DEX- responsive transcriptional repression to the heterologous thymidine kinase basal promoter. We also report that glucocorticoid suppression of 1,25-dihydroxyvitamin D3-stimulated transcription occurs independently of distal or proximal GREs. Taken together, these results demonstrate that in vivo responsiveness of OC to DEX involves the integrative activities of several functional promoter elements.

This article has been cited by other articles:

				A.-M. O'Carroll, S. J Lolait, and G. M Howell Transcriptional regulation of the rat apelin receptor gene: promoter cloning and identification of an Sp1 site necessary for promoter activity J. Mol. Endocrinol., February 1, 2006; 36(1): 221 - 235. [Abstract] [Full Text] [PDF]

				K. Sooy and M. B. Demay Transcriptional Repression of the Rat Osteocalcin Gene by {delta}EF1 Endocrinology, September 1, 2002; 143(9): 3370 - 3375. [Abstract] [Full Text] [PDF]

				H. W. Woitge, J. R. Harrison, A. Ivkosic, Z. Krozowski, and B. E. Kream Cloning and in Vitro Characterization of {{alpha}}1(I)-Collagen 11{{beta}}-Hydroxysteroid Dehydrogenase Type 2 Transgenes as Models for Osteoblast-Selective Inactivation of Natural Glucocorticoids Endocrinology, March 1, 2001; 142(3): 1341 - 1348. [Abstract] [Full Text] [PDF]

				A. E. Kearns, K. Goto, G. Gianakakos, W. Lippmann, and M. B. Demay Transcriptional Repression of the Rat Osteocalcin Gene: Role of Two Intronic CCTCCT Motifs Endocrinology, September 1, 1999; 140(9): 4120 - 4126. [Abstract] [Full Text]

				H. Harada, S. Tagashira, M. Fujiwara, S. Ogawa, T. Katsumata, A. Yamaguchi, T. Komori, and M. Nakatsuka Cbfa1 Isoforms Exert Functional Differences in Osteoblast Differentiation J. Biol. Chem., March 12, 1999; 274(11): 6972 - 6978. [Abstract] [Full Text] [PDF]

				F. Aslam, L. McCabe, B. Frenkel, A. J. van Wijnen, G. S. Stein, J. B. Lian, and J. L. Stein AP-1 and Vitamin D Receptor (VDR) Signaling Pathways Converge at the Rat Osteocalcin VDR Element: Requirement for the Internal Activating Protein-1 Site for Vitamin D-Mediated Trans-Activation Endocrinology, January 1, 1999; 140(1): 63 - 70. [Abstract] [Full Text]

				B. Frenkel, C. Capparelli, M. van Auken, D. B. , J. Bryan, J. L. Stein, G. S. Stein, and J. B. Lian Activity of the Osteocalcin Promoter in Skeletal Sites of Transgenic Mice and during Osteoblast Differentiation in Bone Marrow-Derived Stromal Cell Cultures: Effects of Age and Sex Endocrinology, May 1, 1997; 138(5): 2109 - 2116. [Abstract] [Full Text] [PDF]

				J. B. Lian, V. Shalhoub, F. Aslam, B. Frenkel, J. Green, M. Hamrah, G. S. Stein, and J. L. Stein Species-Specific Glucocorticoid and 1,25-Dihydroxyvitamin D Responsiveness in Mouse MC3T3-E1 Osteoblasts: Dexamethasone Inhibits Osteoblast Differentiation and Vitamin D Down-Regulates Osteocalcin Gene Expression Endocrinology, May 1, 1997; 138(5): 2117 - 2127. [Abstract] [Full Text] [PDF]

				B. Guo, F. Aslam, A. J. van Wijnen, S. G. E. Roberts, B. Frenkel, M. R. Green, H. DeLuca, J. B. Lian, G. S. Stein, and J. L. Stein YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin gene PNAS, January 7, 1997; 94(1): 121 - 126. [Abstract] [Full Text] [PDF]